# Withdrawal or Reduction TKIs in CML-CP

> **NCT04143087** · — · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 100 (estimated)

## Conditions studied

- MMR on 12 Month

## Interventions

- **DRUG:** withdrawal TKIs or halve TKIs

## Key facts

- **NCT ID:** NCT04143087
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-23
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04143087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04143087, "Withdrawal or Reduction TKIs in CML-CP". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04143087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
